SGMO Competitors & Alternatives

Compare Sangamo Therapeutics Inc with similar stocks in the same industry

Biotechnology

SGMO

Main Stock
$0.18
+31.56%
Tradestie Score
52
Market Cap
$203.53M
Revenue Growth
88.4%
Analyst Upside
+2011.5%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 4/10 Genomics Precision Med Gene Editing
Competitive Moat: None
Core Technology Stack: Zinc Finger Nucleases, AAV Delivery, Gene Editing, Cell Therapy Manufacturing
Major Customers 5
Pfizer Takeda Biogen Novartis Academic Research Institutions
Critical Suppliers 5
AAV Vector Manufacturers Contract Research Organizations Reagent Suppliers Clinical Trial Sites Manufacturing CDMOs
Direct Ecosystem Rivals 4

Top Competitors

221 stocks in Biotechnology
Company Price Market Cap P/E Score Action
LAZR Luminar Technologies, Inc. Class A Common Stock
$27.12
-7.28%
$135.12M - 44 Compare
CLYM Climb Bio, Inc. Common Stock
$10.00
-3.52%
$133.50M - 41 Compare
SRZN Surrozen, Inc. Common
$32.94
+4.21%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$27.77
-5.99%
$110.20M - 32 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.04
-2.25%
$84.52M - 47 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.59
-3.19%
$67.94M - 48 Compare
TPIC TPIC
- - - - Compare
MEIP MEIP
- - - 49 Compare
LANC LANC
- - - - Compare
AFMD AFMD
- - - - Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)

221 stocks in this industry